S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NYSE:DXC

DXC Technology (DXC) Stock Forecast, Price & News

$25.67
+0.59 (+2.35%)
(As of 06/6/2023 ET)
Compare
Today's Range
$24.88
$25.78
50-Day Range
$22.24
$25.70
52-Week Range
$22.11
$36.00
Volume
1.50 million shs
Average Volume
1.74 million shs
Market Capitalization
$5.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.75

DXC Technology MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
23.7% Upside
$31.75 Price Target
Short Interest
Bearish
3.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.58
Upright™ Environmental Score
News Sentiment
0.00mentions of DXC Technology in the last 14 days
Based on 13 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.54%
From $3.84 to $4.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Computer And Technology Sector

395th out of 606 stocks

Data Processing & Preparation Industry

32nd out of 62 stocks


DXC stock logo

About DXC Technology (NYSE:DXC) Stock

DXC Technology Co. provides technology consulting, outsourcing and support services. It operates through the following segments: Global Business Services (GBS) and Global Infrastructure Services (GIS). The GBS segment provides technology solutions that help clients address challenges and accelerate the digital transformations that are tailored to each client's specific objectives. The GIS segment provides a portfolio of technology offerings that deliver predictable outcomes and measurable results while reducing business risk and operational costs for customers. The company was founded in 1959 and is headquartered in Ashburn, VA.

Receive DXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DXC Technology and its competitors with MarketBeat's FREE daily newsletter.

DXC Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
DXC Technology (NYSE: DXC)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
DXC Technology (NYSE:DXC) Updates FY 2024 Earnings Guidance
DXC - DXC Technology Company
DXC Technology (NYSE:DXC) Price Target Cut to $27.00
DXC Technology (NYSE:DXC) Updates FY24 Earnings Guidance
DXC Technology CFO Ken Sharp Quits; Rob Del Bene Named Replacement
Q4 2023 DXC Technology Co Earnings Call
DXC Technology (NYSE:DXC) Issues Quarterly Earnings Results
See More Headlines

DXC Price History

DXC Company Calendar

Last Earnings
5/18/2023
Today
6/06/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Employees
130,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$31.75
High Stock Price Forecast
$38.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+26.6%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

Net Income
$-568,000,000.00
Pretax Margin
-6.13%

Debt

Sales & Book Value

Annual Sales
$14.43 billion
Cash Flow
$10.11 per share
Book Value
$16.78 per share

Miscellaneous

Free Float
210,281,000
Market Cap
$5.30 billion
Optionable
Optionable
Beta
1.95

Key Executives

  • Michael J. Salvino
    Chairman, President & Chief Financial Officer
  • Jonathan Robson
    President
  • Jim Brady
    Chief Operating Officer
  • Kenneth P. Sharp
    Chief Financial Officer & Executive Vice President
  • Kristie Grinnell
    Chief Information Officer & Senior Vice President













DXC Stock - Frequently Asked Questions

Should I buy or sell DXC Technology stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DXC Technology in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DXC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DXC, but not buy additional shares or sell existing shares.
View DXC analyst ratings
or view top-rated stocks.

What is DXC Technology's stock price forecast for 2023?

10 Wall Street research analysts have issued twelve-month price targets for DXC Technology's stock. Their DXC share price forecasts range from $25.00 to $38.00. On average, they predict the company's stock price to reach $31.75 in the next twelve months. This suggests a possible upside of 26.6% from the stock's current price.
View analysts price targets for DXC
or view top-rated stocks among Wall Street analysts.

How have DXC shares performed in 2023?

DXC Technology's stock was trading at $26.50 at the beginning of the year. Since then, DXC stock has decreased by 5.4% and is now trading at $25.08.
View the best growth stocks for 2023 here
.

Are investors shorting DXC Technology?

DXC Technology saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 7,710,000 shares, an increase of 12.6% from the April 15th total of 6,850,000 shares. Based on an average trading volume of 1,620,000 shares, the short-interest ratio is presently 4.8 days. Approximately 3.4% of the company's shares are sold short.
View DXC Technology's Short Interest
.

When is DXC Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our DXC earnings forecast
.

How were DXC Technology's earnings last quarter?

DXC Technology (NYSE:DXC) posted its earnings results on Thursday, May, 18th. The company reported $1.02 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.02. The firm earned $3.59 billion during the quarter, compared to the consensus estimate of $3.62 billion. DXC Technology had a negative net margin of 3.94% and a positive trailing twelve-month return on equity of 17.23%. The firm's quarterly revenue was down 10.4% compared to the same quarter last year. During the same period last year, the business posted $0.84 earnings per share.
Read the conference call transcript
.

What guidance has DXC Technology issued on next quarter's earnings?

DXC Technology updated its first quarter 2024 earnings guidance on Friday, May, 26th. The company provided earnings per share guidance of $0.80-$0.85 for the period, compared to the consensus earnings per share estimate of $0.92. The company issued revenue guidance of $3.54 billion-$3.58 billion, compared to the consensus revenue estimate of $3.61 billion.

What is Mike Salvino's approval rating as DXC Technology's CEO?

1,508 employees have rated DXC Technology Chief Executive Officer Mike Salvino on Glassdoor.com. Mike Salvino has an approval rating of 77% among the company's employees.

What other stocks do shareholders of DXC Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DXC Technology investors own include Hewlett Packard Enterprise (HPE), NVIDIA (NVDA), AT&T (T), HP (HPQ), Alibaba Group (BABA), AbbVie (ABBV), CVS Health (CVS), Boeing (BA), Bank of America (BAC) and Micron Technology (MU).

What is DXC Technology's stock symbol?

DXC Technology trades on the New York Stock Exchange (NYSE) under the ticker symbol "DXC."

Who are DXC Technology's major shareholders?

DXC Technology's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Franklin Resources Inc. (8.14%), BlackRock Inc. (6.89%), Victory Capital Management Inc. (4.10%), Glenview Capital Management LLC (3.93%), State Street Corp (3.48%) and Dimensional Fund Advisors LP (2.70%). Insiders that own company stock include Raul J Fernandez, Raul J Fernandez, William L Deckelman Jr and William L Deckelman, Jr.
View institutional ownership trends
.

How do I buy shares of DXC Technology?

Shares of DXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DXC Technology's stock price today?

One share of DXC stock can currently be purchased for approximately $25.08.

How much money does DXC Technology make?

DXC Technology (NYSE:DXC) has a market capitalization of $5.30 billion and generates $14.43 billion in revenue each year. The company earns $-568,000,000.00 in net income (profit) each year or ($2.58) on an earnings per share basis.

How many employees does DXC Technology have?

The company employs 130,000 workers across the globe.

How can I contact DXC Technology?

DXC Technology's mailing address is 1775 TYSONS BOULEVARD, TYSONS VA, 22102. The official website for the company is www.dxc.technology. The company can be reached via phone at (703) 245-9700, via email at investor.relations@dxc.com, or via fax at 310-640-2648.

This page (NYSE:DXC) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -